Using animal models to test a neurodevelopmental hypothesis of schizophrenia

Journal of Psychiatry and Neuroscience

Volumn 29, Issue 4, 2004, Pages 282-286

  Lipska, Barbara K ^a,b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b Bldg 10 ^*  (United States)

Author keywords

Animal; Antipsychotic agents; Hippocampus; Models; Neurons; Nucleus accumbens; Prefrontal cortex; Schizophrenia

Indexed keywords

AMPA RECEPTOR ANTAGONIST; BROXURIDINE; DECAHYDRO 6 [2 (1H TETRAZOL 5 YL)ETHYL] 3 ISOQUINOLINECARBOXYLIC ACID; DOPAMINE; NEUROLEPTIC AGENT;

BEHAVIOR; BEHAVIOR DISORDER; BRAIN DYSFUNCTION; BRAIN REGION; CLINICAL FEATURE; CLINICAL OBSERVATION; CONFERENCE PAPER; CORPUS STRIATUM; DENTATE GYRUS; DEVELOPMENTAL STAGE; DISEASE COURSE; DISEASE MODEL; DRUG TARGETING; HIPPOCAMPUS; HUMAN; HYPOTHESIS; MEMORY DISORDER; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NERVE TRACT; NERVOUS SYSTEM DEVELOPMENT; NEUROANATOMY; NEUROBIOLOGY; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; PATHOLOGICAL ANATOMY; PREFRONTAL CORTEX; SCHIZOPHRENIA; SOCIAL DISABILITY; VALIDATION PROCESS; WORKING MEMORY;

ANIMALS; CORPUS STRIATUM; DENTATE GYRUS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; NERVE NET; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; SCHIZOPHRENIA;

EID: 4444316217     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Costall B, Naylor RJ. Animal neuropharmacology and its prediction of clinical response. In: Hirsch SR, Weinberger DR, editors. Schizophrenia. Oxford: Blackwell Science; 1995. p. 401-24.
2. Lipska BK, Jaskiw GE, Weinberger DR. Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal hippocampal damage: a potential animal model of schizophrenia. Neuropsychopharmacology 1993;9:67-75.
3. Flores G, Barbeau D, Quirion R, Srivastava LK. Decreased binding of dopamine D3 receptors in limbic subregions after neonatal bilateral lesion of rat hippocampus. J Neurosci 1996;16:2020-6.
4. Chambers RA, Moore J, McEvoy JP, Levin ED. Cognitive effects of neonatal hippocampal lesions in a rat model of schizophrenia. Neuropsychopharmacology 1996;15:587-94.
5. Wan RQ, Giovanni A, Kafka SH, Corbett R. Neonatal hippocampal lesions induced hyperresponsiveness to amphetamine: behavioral and in vivo microdialysis studies. Behav Brain Res 1996;78:211-23.
6. Wan RQ, Corbett R. Enhancement of postsynaptic sensitivity to dopaminergic agonists induced by neonatal hippocampal lesions. Neuropsychopharmacology 1997;16:259-68.
7. Wan RQ, Hartman H, Corbett R. Alteration of dopamine metabolites in CSF and behavioral impairments induced by neonatal hippocampal lesions. Physiol Behav 1998;65:429-36.
8. Black MD, Lister S, Hitchcock JM, Giersbergen P, Sorensen SM. Neonatal hippocampal lesion model of schizophrenia in rats: sex differences and persistence of effects into maturity. Drug Dev Res 1998;43:206-13.
9. Brake WG, Sullivan RM, Flores G, Srivastava L, Gratton A. Neonatal ventral hippocampal lesions attenuate the nucleus accumbens dopamine response to stress: an electrochemical study in the rat. Brain Res 1999;831:25-32.
10. Becker A, Grecksch G, Bernsteinn HG, Hollt V, Bogerts B. Social behavior in rats lesioned with ibotenic acid in the hippocampus: quantitative and qualitative analysis. Psychopharmacology 1999;144:333-8.
11. Grecksch G, Bernstein HG, Becker A, Hollt V, Bogerts B. Disruption of latent inhibition in rats with postnatal hippocampal lesions. Neuropsychopharmacology 1999;20:525-32.
12. Schroeder H, Grecksch G, Becker A, Bogerts B, Höllt V. Alterations of the dopaminergic and glutamatergic neurotransmission in adult rats with postnatal ibotenic acid hippocampal lesion. Psychopharmacology 1999;145:61-6.
13. Beauregard M, Bachevalier J. Neonatal insult to the hippocampal region and schizophrenia: a review and a putative animal model. Can J Psychiatry 1996;41(7):446-56.
14. Bertolino A, Saunders RC, Mattay VS, Bachevalier J, Frank JA, Weinberger DR. Altered development of prefrontal neurons in rhesus monkeys with neonatal mesial temporo-limbic lesions: a proton magnetic resonance spectroscopic imaging study. Cereb Cortex 1997;7:740-8.
15. Saunders RC, Kolachana BS, Bachevalier J, Weinberger DR. Neonatal lesions of the temporal lobe disrupt prefrontal cortical regulation of striatal dopamine. Nature 1998;393:169-71.
16. Bachevalier J, Alvarado MC, Malkova L. Memory and socioemotional behavior in monkeys after hippocampal damage incurred in infancy or in adulthood. Biol Psychiatry 1999;46(3):329-39.
17. Weinberger DR. Cell biology of the hippocampal formation in schizophrenia. Biol Psychiatry 1999;45:395-402.
18. Jay TM, Glowinski J, Thierry AM. Selectivity of the hippocampal projection to the prelimbic area of the prefrontal cortex in the rat. Brain Res 1989;505:337-40.
19. Carr DB, Sesack SR. Hippocampal afferents to the rat prefrontal cortex: synaptic targets and relation to dopaminergic terminals. J Comp Neurol 1996;369:1-15.
20. Suddath RL, Christisin GW, Torrey EF, Casanova M, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Eng J Med 1990;322:789-94.
21. Sams-Dodd F, Lipska BK, Weinberger DR. Neonatal lesions of the rat ventral hippocampus result in hyperlocomotion and deficits in social behaviour in adulthood. Psychopharmacology 1997;132:303-10.
22. Lipska BK, Weinberger DR. Subchronic treatment with haloperidol or clozapine in rats with neonatal excitotoxic hippocampal damage. Neuropsychopharmacology 1994;10:199-205.
23. Lipska BK, Weinberger DR. Gonadectomy does not prevent novelty- or drug-induced hyperresponsiveness in rats with neonatal excitotoxic hippocampal damage. Dev Brain Res 1994;78:253-8.
24. Lipska BK, Swerdlow NR, Geyer MA, Jaskiw GE, Braff DL, Weinberger DR. Neonatal excitotoxic hippocampal damage in rats causes postpubertal changes in prepulse inhibition of startle and its disruption by apomorphine. Psychopharmacology 1995;122:35-43.
25. Lipska BK, Aultman JM, Verma A, Weinberger DR, Moghaddam B. Neonatal damage of the ventral hippocampus impairs working memory in the rat. Neuropsychopharmacology 2002;27:47-54.
26. Al-Amin HA, Weinberger DR, Lipska BK. Exaggerated MK-801-induced motor hyperactivity in rats with the neonatal lesion of the ventral hippocampus. Behav Pharmacology 2000;11:269-78.
27. Al-Amin HA, Weickert CS, Lillrank SM, Weinberger DR, Lipska BK. Delayed onset of enhanced MK-801-induced motor hyperactivity after neonatal lesions of the rat ventral hippocampus. Biol Psychiatry 2001;49:528-39.
28. Hori T, Subramaniam S, Srivastava LK, Quirion R. Behavioral and neurochemical alterations following repeated phencyclidine administration in rats with neonatal ventral hippocampal lesions. Neuropharmacology 2000;39:2478-91.
29. Chambers RA, Self DW. Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia. Neuropsychopharmacology 2002;26:889-905.
30. Le Pen G, Gaudet L, Mortas P, Mory R, Moreau JL. Deficits in reward sensitivity in a neurodevelopmental rat model of schizophrenia. Psychopharmacology (Berl) 2002;161:434-41.
31. Lipska BK, Al-Amin HA, Weinberger DR. Excitotoxic lesions of the rat medial prefrontal cortex: effects on abnormal behaviors associated with neonatal hippocampal damage. Neuropsychopharmacology 1998;19:451-64.
32. Weinberger DR, Lipska BK. Cortical maldevelopment, antipsychotic drugs, and schizophrenia: in search of common ground. Schizophr Res 1995;16:87-110.
33. Lipska BK, Chrapusta SJ, Egan MF, Weinberger DR. Neonatal excitotoxic ventral hippocampal damage alters dopamine response to mild chronic stress and haloperidol treatment. Synapse 1995;20:125-30.
34. Bertolino A, Roffman JL, Lipska BK, Van Gelderen P, Olson A, Weinberger DR. Postpubertal emergence of prefrontal neuronal deficits and altered dopaminergic behaviors in rats with neonatal hippocampal lesions. Cereb Cortex 2002;12:983-90.
35. Lee CJ, Binder T, Lipska BK, Zhu Y, Weinberger DR, Nakabeppu Y, et al. Neonatal ventral hippocampal lesions produce an elevation of Δ-FosB-like protein(s) in the rodent neocortex. Abstr Soc Neurosci 1998;24:489.
36. Ashe P, Chlan-Fourney J, Juorio AV, Li XM. Brain-derived neurotrophic factor (BDNF) mRNA in rats with neonatal ibotenic acid lesions of the ventral hippocampus. Brain Res 2002;956(1):126-35.
37. O'Donnell P, Lewis BL, Lerman D, Weinberger DR, Lipska BK. Effects of neonatal hippocampal lesions on prefrontal cortical pyramidal cell responses to VTA stimulation. Cereb Cortex 2002;12:975-82.
38. Nadri C, Lipska BK, Kozlovsky N, Weinberger DR, Belmaker RH, Agam G. GSK-3β levels and activity in a neurodevelopmental rat model of schizophrenia. Brain Res Dev Brain Res 2003;141:33-7.
39. Lipska BK, Lerman DN, Khaing ZZ, Weinberger DR. The neonatal ventral hippocampal lesion model of schizophrenia: effects on dopamine and GABA mRNA markers in the rat brain. Eur J Neurosci 2003;18:3097-104.
40. Lipska BK, Lerman DN, Khaing ZZ, Weickert CS, Weinberger DR. Gene expression in dopamine and GABA systems in an animal model of schizophrenia: effects of antipsychotic drugs. Eur J Neurosci 2003;18:391-402.
41. Spanagel R, Weiss F. The dopamine hypothesis of reward: past and current status. Trends Neurosci 1999;22:521-7.
42. Abi-Dargham A, Gil R, Krystal J, Baldwin RM, Seibyl JP, Bowers M, et al. Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry 1998;155:761-7.
43. Laruelle M, Abi-Dargham A, van Dyck CH, Gil R, D'Souza CD, Erdos J, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A 1996;93:9235-40.
44. Robinson TE, Kolb B. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997;17:8491-7.
45. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry 2000;57:65-73.
46. Lipska BK, Kolb B, Halim N, Weinberger DR. Synaptic abnormalities in prefrontal cortex and nucleus accumbens of adult rats with neonatal hippocampal damage. Schizophr Res 2001; 49:47.
47. Lieberman JA, Sheitman BB, Kinon BJ. Neurochemical sensitization in the pathophysiology of schizophrenia: deficits and dysfunction in neuronal regulation and plasticity. Neuropsychopharmacology 1997;17(4):205-29.
48. Le Pen G, Moreau JL. Disruption of prepulse inhibition of startle reflex in a neurodevelopmental model of schizophrenia: reversal by clozapine, olanzapine and risperidone but not by haloperidol. Neuropsychopharmacology 2002;27:1-11.
49. Sershen H, Harsing LG, Lipska BK, O'Donnell P. High Gly: role of glycine transporter in regulation of NMDA function [abstract]. 35th Annual Winter Conference on Brain Research; 2002 Jan 26-Feb 2; Snowmass (CO).
50. Lipska BK, Halim ND, Segal PN, Weinberger DR. Effects of reversible inactivation of the neonatal ventral hippocampus on behavior in the adult rat. J Neurosci 2002;22:2835-42.
51. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology 2000;23:223-39.
52. Lipska BK, Weinberger DR. Genetic variation in vulnerability to the behavioral effects of neonatal hippocampal damage in rats. Proc Natl Acad Sci U S A 1995;92:8906-10.